In 2021, Frank H. Laukien, Ph.D. earned $820.28K in total compensation at Bruker, primarily from $811.58K salary. Most recently acquired 40,000 shares in Feb 2025. Currently holds stock worth $1.86B. Has donated $61.82M in stock to charitable causes. Led Bruker as CEO for 3 years.
Compensation History
Annual executive compensation data for Frank H. Laukien, Ph.D., including salary, bonuses, and stock awards.
Year
2021
Total Compensation
$820.28K
Salary
$811.58K
Bonus
$0.00
Other
$8.70K
Salary
$811.58KBoard Justification
The compensation philosophy aligns with company performance, peer benchmarking, and retention strategies, focusing on competitive compensation that recognizes contributions to Bruker.
Bonus
$0.00Board Justification
No bonus was reported for 2021.
Other Compensation
$8.70KBoard Justification
This amount represents a matching contribution made by Bruker to a 401(k) plan for the benefit of the CEO.
Restricted Stock
Board Justification
No vested stock was reported for 2021.
Performance Metrics
Performance metrics included financial performance goals linked to the company's overall performance.
Frank H. Laukien, Ph.D.
Founder and Ex-CEO of Bruker
Education
Ph.D. in Physics from the University of Massachusetts.
Field of Expertise
Other - Science
Sector of Economy
Healthcare
Born
January 1, 1950 - 75 years ago
CEO of Bruker for
3 years 6 months (Feb 2018 - Aug 2021)
Previous Experience
Chairman and President of Bruker Corporation since its inception.
Other Bruker CEOs
Holdings
Track Frank H. Laukien, Ph.D.'s stock holdings and portfolio value over time.
Total Stock Sold
$106.70M
$106.70M
1,762,531 BRKR shares
What if they kept their stock?
If Frank H. Laukien, Ph.D. didn't sell their stock, today they would have:
Extra BRKR1,762,531 shares worth $84.99M.
This is -20.35% and $21.71M less than what they got when they sold the stock.
Charitable Transactions
1,281,941 shares
BRKR
Recent Charitable Transactions
48,908 shares
BRKR
Dec 16, 2019
Charity
22,820 shares
BRKR
Apr 7, 2016
Charity
1,210,213 shares
BRKR
Dec 31, 2012
Charity
Insider Trading
Frank H. Laukien, Ph.D.'s recent stock transactions, purchases, and sales filed with the SEC.
$2.04M
BRKR at $50.99/share
Feb 18, 2025
Purchase
$5.07M
BRKR at $50.67/share
Nov 18, 2024
Purchase
28,307 shares
BRKR
Aug 9, 2024
Received
38,521 shares
BRKR
Aug 10, 2023
Received
$2.46M
BRKR at $64.81/share
Aug 8, 2023
Sale
$14.62M
BRKR at $73.12/share
May 15, 2023
Sale
$15.31M
BRKR at $76.53/share
May 8, 2023
Sale
$1.30M
BRKR at $79.21/share
May 3, 2023
Sale
$14.41M
BRKR at $78.51/share
May 1, 2023
Sale
$16.00M
BRKR at $80.01/share
Apr 24, 2023
Sale
Rivals
Compare Frank H. Laukien, Ph.D. with competitor CEOs and industry peers.
Patrick Kaltenbach
CEO of Mettler-Toledo International, Inc.
2023 Compensation
Stock
$0.00
Salary
$1.00M
Bonus
$155.16K
Other
$355.86K
Total Holdings
$7.79M
Olivier A. Filliol
CEO of Mettler-Toledo International, Inc.
2023 Compensation
Stock
$0.00
Salary
$26.67K
Bonus
$11.93K
Other
$11.93K
Total Holdings
$26.26M
Prahlad Singh
CEO of Revvity
2023 Compensation
Stock
$7.54M
Salary
$1.09M
Bonus
$0.00
Other
$32.48K
Total Holdings
$23.60M
Marc N. Casper
CEO of Thermo Fisher Scientific
2024 Compensation
Stock
$0.00
Salary
$1.74M
Bonus
$5.51M
Other
$537.49K
Total Holdings
$1.17B